Literature DB >> 3620442

Unfolding pathway of myoglobin: effect of denaturants on solvent accessibility to tyrosyl residues detected by second-derivative spectroscopy.

R Ragone, G Colonna, E Bismuto, G Irace.   

Abstract

The effects of denaturants on the solvent accessibility to tyrosyl residues of apomyoglobin have been examined by means of second-derivative spectroscopy in the near-ultraviolet. Three apomyoglobins, i.e., sperm whale, horse, and tuna, were selected because of the different distribution of tyrosyl residues in their primary structure. The results are consistent with the occurrence of two independent consecutive events in the guanidine-induced denaturation pattern of apomyoglobin. The first event, which is responsible for the lack of the ability to bind the heme, has been proved to involve conformational changes in both the domains, i.e., segments 1-79 and 80-153, identified in the myoglobin molecule. However, the conformational changes are not of the same type. In fact, the solvent accessibility to tyrosine HC2 is increased probably because of a partial unfolding of the 80-153 domain. Conversely, the solvent accessibility to tyrosine B2 is decreased, thus indicating that a refolding occurs in some region of the N-terminal moiety (1-79 domain) of the molecule.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3620442     DOI: 10.1021/bi00382a010

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  2 in total

1.  Structural analysis of botulinum neurotoxin types A and E in aqueous and nonpolar solvents by Fourier transform infrared, second derivative UV absorption, and circular dichroic spectroscopies.

Authors:  B R Singh; F M Wasacz; S Strand; R J Jakobsen; B R DasGupta
Journal:  J Protein Chem       Date:  1990-12

2.  Characterization of multiple stable conformers of the EC5 domain of E-cadherin and the interaction of EC5 with E-cadherin peptides.

Authors:  Kai Zheng; Jennifer S Laurence; Krzysztof Kuczera; Gennady Verkhivker; C Russell Middaugh; Teruna J Siahaan
Journal:  Chem Biol Drug Des       Date:  2009-06       Impact factor: 2.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.